Crystalline forms of plasma kallikrein inhibitors
US11306061B2 · kind B2 · utility
1Cited by
4References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 2020 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Jul 7, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pure crystalline forms of 1-benzyl-N-(4-carbamimidoylbenzyl)-1H-pyrazole-4-carboxamide acetate, and an amorphous form, pharmaceutical compositions thereof, and methods for making the same, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.